Publicacións en colaboración con investigadores/as de Hospital Universitario de la Princesa (16)

2022

  1. Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

    Neurologia, Vol. 37, Núm. 5, pp. 390-402

2020

  1. Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine

    Neurologia, Vol. 35, Núm. 8, pp. 568-578

2019

  1. Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice

    Neurologia, Vol. 34, Núm. 6, pp. 408-417

  2. Self-reported periodontitis and migraine: results from a multicenter, cross-sectional survey in Spain

    Odontology, Vol. 107, Núm. 4, pp. 530-535

2018

  1. OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study

    European Journal of Neurology, Vol. 25, Núm. 2, pp. 411-416

2011

  1. Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke

    Stroke, Vol. 42, Núm. 10, pp. 2813-2818

2010

  1. Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: How well are we correcting it?: Implications for outcome

    Stroke, Vol. 41, Núm. 10, pp. 2362-2365

2009

  1. The prognostic value of capillary glucose levels in acute stroke the GLycemia in acute stroke (GLIAS) study

    Stroke, Vol. 40, Núm. 2, pp. 562-568

2008

  1. High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA

    Stroke, Vol. 39, Núm. 7, pp. 2006-2010

  2. Marcadores moleculares asociados a signos precoces de isquemia en tomografía computarizada cerebral

    Neurologia, Vol. 23, Núm. 4, pp. 220-225

2007

  1. Statin treatment withdrawal in ischemic stroke: A controlled randomized study

    Neurology, Vol. 69, Núm. 9, pp. 904-910

2006

  1. High blood pressure and inflammation are associated with poor prognosis in lacunar infarctions

    Cerebrovascular Diseases, Vol. 22, Núm. 2-3, pp. 123-129

  2. Hyperthermia is a surrogate marker of inflammationmediated cause of brain damage in acute ischaemic stroke

    Journal of Internal Medicine, Vol. 260, Núm. 4, pp. 343-349

  3. New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke

    Neurology, Vol. 67, Núm. 11, pp. 1973-1978

2005

  1. Increased plasma levels of 15-deoxy Δ prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke

    Stroke, Vol. 36, Núm. 6, pp. 1189-1194

  2. The prediction of malignant cerebral infarction by molecular brain barrier disruption markers

    Stroke, Vol. 36, Núm. 9, pp. 1921-1926